Overview
Key stats
Fundamentals Sep 10- Open
- $62.50
- 52-wk high
- $147.03
- High
- $67.72
- 52-wk low
- $38.91
- Low
- $62.01
- Prev close
- $62.14
- Mkt cap
- $1.92B
- P/E
- 14.7x
- Volume
- 1.20M
- Fwd P/E
- 53.5x
- Beta
- 0.70
- P/S
- 2.1x
- P/B
- 2.2x
- Profit margin
- +15.0%
- Op margin
- -0.3%
- ROE
- +18.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in $0.36 a share above what analysts expected.
Earnings per share
-$0.22 expected
Reports Nov 2, 2026, in 53 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $224.5M | $269.1M | $204.6M | $200.6M |
| Cost of what it sold | $31.8M | $36.1M | $27.7M | $29.1M |
| Gross profit | $192.7M | $233.0M | $176.9M | $171.5M |
| What it spent | ||||
| Research and development | $24.2M | $24.9M | $25.8M | $24.7M |
| Sales and admin | $122.5M | $162.0M | $152.2M | $147.3M |
| Other operating costs | $36.4M | — | — | — |
| Total operating expenses | $183.1M | $186.9M | $178.0M | $172.0M |
| What was left | ||||
| Operating profit | $9.6M | $46.1M | -$1.1M | -$514.0K |
| Interest on debt | $11.0K | $122.0K | — | — |
| Profit before tax | $13.6M | $50.3M | $2.4M | $3.1M |
| Tax | $3.6M | -$85.8M | $13.7M | $2.8M |
| Net profit | $9.9M | $136.1M | -$11.3M | $314.0K |
| EBITDA | $17.2M | $54.3M | $7.5M | $4.1M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Tone of tracked coverage
Why Is Inspire (INSP) Down 4.1% Since Last Earnings Report?
NeutralSep 2Understanding the Setup: (INSP) and Scalable Risk
Leans bearishSep 1Inspire Medical August 2026 slides: $10B market opportunity meets reimbursement reset
Leans bullishAug 31Inspire Medical Systems, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Leans bullishAug 26Inspire Medical Systems (INSP) holder to sell 64 shares in 2026
NeutralAug 24Inspire Medical Systems (INSP) Stock Analysis: Navigating the Sleep Apnea Market with High Valuation and Mixed Ratings
NeutralAug 24
Macro
11 macro signals shaping INSP right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results